Our corporate social responsibility programmes
GSK India focuses on need-based community initiatives to address specified national objectives and assist people from vulnerable communities. We work with our partners to address specific national health priorities in line with select UN Sustainable Development Goals (SDGs). Our company contributes to nation-building through CSR programmes centred on healthcare and education. We work towards supporting meritorious students from underserved backgrounds to pursue their education in Medicine. In addition, we are working towards eliminating lymphatic filariasis and focusing on child nutrition under the National Urban Health Mission (NUHM).In FY 2022-23, our CSR support in India spanned
Source: internal data
GSK Scholars programme - Enabling future healthcare professionals
The GSK Scholars programme, our flagship CSR initiative in India is aimed at enabling future healthcare professionals in the country.
Objective: To help India's skill-building strategy and to enhance science, technology, engineering and mathematics (STEM) education in the country.
Offering: This scholarship provides students with up to Rs. 1 lakh each year for four-and-a-half years to defray academic expenditures related to their MBBS programme.
Value creation: Currently supporting 398 scholars, the programme has made a significant impact on advancing Science, Technology, Engineering, and Mathematics (STEM) education and shaping the future of healthcare professionals in India.
Partnering India to eliminate Lymphatic Filariasis (LF)
Objective: Eliminate Lymphatic Filariasis as a public health issue from the country.
Offering: Contributing albendazole tablets used during mass drug administration (MDA) to the World Health Organization (WHO) until LF is completely eliminated in India.
GSK India is dedicated to eliminating lymphatic filariasis (LF) as a public health concern. In collaboration with the World Health Organization (WHO), since 2000, GSK has been leading mass drug administration (MDA) efforts in affected regions. Commonly known as elephantiasis, LF is a debilitating disease, causing severe pain and disfigurement, with profound social and psychological impact, and it stands as a primary cause of permanent disability globally.
Value creation In FY 2023-24, the company has contributed 44.5 million albendazole tablets and till date, it has contributed 3.96 billion albendazole tablets.
Mother and child health
Objective: To enhance the health and nutrition status of children, mothers, and adolescents by developing resilient communities with active participation of system and community stakeholders to reduce public health risks in vulnerable communities at Mumbai, India.
Offerings: This intervention project has worked directly with ~2,716 married women in the reproductive age group (MWRA), 1,964 children aged 0-5 years and 334 adolescents in the 10-19 years age group leading to improved access of public healthcare services, better awareness on maternal and child health topics in India.
Upgrading classrooms to smart classes
Objective: To transform the way students learn by upgrading classrooms into smart classes.
Offering: As part of this programme, 54 smart-classes have been created benefitting children in Nashik Municipal Corporation (NMC) and Nashik’s Zilla Parishad schools.
Value creation: The project has benefited 11,027 students till date. The incorporation of digital technology has led to a notable increase in student attendance and overall learning outcomes.
Be a Change-maker (Together Day - employee volunteering programme)
Objective: To redirect our company's people's efforts towards social benefit and try to build communities as 'Changemakers'.
Offering: Our Company volunteers across India for various charitable causes. In addition, it has developed a mentoring programme in which our company’s people who are volunteers mentor students studying medicine at government colleges. These students are part of the GSK Scholars programme, which connects employee involvement with the CSR initiative.
Solar Panel Initiative
Water replenishment project
Water plays a vital role in your company’s sustainability strategy, as it is essential for human health and sustainable manufacturing of its vaccines and medications.
For its sites and key suppliers located in water-stressed areas, your company is developing catchment-level water replenishment, restoration and regeneration projects to realise its water neutrality target. Your company has partnered with the Watershed Organisation Trust (WOTR) in Nashik on a water replenishment project designed to improve ecosystem conditions, enhance the climate resilience of local agriculture and empower local villages to manage water resources and improve the health and livelihoods of the villagers.
Women+Water Collaborative
GSK India is a founding partner of the Women + Water Collaborative in India, which launched in October 2023, working with the Water Resilience Coalition, an initiative between the UN-Global Compact and the Pacific Institute. This programme brings together companies from different sectors to leverage women’s leadership for improving access to clean water and sanitation, ultimately supporting the health of local communities. The Women + Water Collaborative aims to enhance water availability and quality in key river basins by implementing water replenishment and conservation techniques, including rainwater harvesting. It also delivers safe drinking water and climate-resilient sanitation and hygiene facilities to communities.
Positive takeaways
Winner of the 2023 GSK’s Global Sustainability Committee (GSC) Sustainability Trophy in the Water Category
4500 KL Rainwater Harvest Pond completed providing 1.5 months of Summer Water Supply
Trust in Science initiative
Objective: This initiative aims to bridge the talent gap and empower the next generation of scientific leaders.
Offering: The initiative will assist 12 PhD candidates for about seven years. Recognising the critical shortage of highly skilled biostatisticians and bioinformatics specialists, your company has joined forces with the Regional Centre for Biotechnology, and launched the 'Trust in Science' programme in India.
Value creation: The initiative has benefited 4,926 households; thereby positively impacting the lives of 5,295 direct beneficiaries.
Home away from home
Objective: GSK India is providing a nurturing environment for underprivileged families whose children are undergoing cancer treatment.
Offering: Recognising the importance of emotional support during this challenging period, the initiative offers a 'home away from home', holistic care during the period of the child's treatment.
Value creation: This project has created a significant impact on the lives of more than 161 families and 483 beneficiaries.
Educational outreach programme
Objective: The project aims to enhance knowledge, skills, and career guidance for students in grades 6-12.
Offering: In the Valsad district of South Gujarat, your company is addressing the challenge of accessing quality education among the tribal population through the educational outreach programme.
Value creation: 16,900 Children benefited across 165 schools.
Regional Projects
Save lives
GSK India addresses maternal and child health issues through awareness programmes, sensitisation efforts, nutrition health camps and medical centre registrations in Nayabasti slum, Kolkata, primarily inhabited by daily wage labourers facing limited access to healthcare services.
Value creation
- 1,030
households
Mainstreaming out of school children
This project aims to elevate beneficiaries to grade-level competencies through access to quality education, nutrition, and healthcare for children aged 6 to 14 years and upon completion, beneficiaries are seamlessly integrated into government schools for continued education.
Value creation
- 401
children
Holistic care for the underserved
Your company has extended its support to empowering underprivileged and deprived girls. Together, they offer free residential formal school education, co-curricular activities, and vocational training, emphasising holistic development.
Value creation
- 192
girls enrolled
